Paul Negulescu, Cahalan Lab postdoc alumnus, now at Vertex Inc, 2024 Breakthrough Prize for development of effective drugs to treat cystic fibrosis. Posted: 2024-01-12 Source: News Type: Features & Briefs share Paul Negulescu, Cahalan Lab postdoc alumnus, now at Vertex Inc, 2024 Breakthrough Prize for development of effective drugs to treat cystic fibrosis. Media Contacts Matt Miller Director, Communications and Public Relations mrmille2@uci.edu Michelle Strombeck Manager, Communications and Public Relations 312-498-8208 mstrombe@hs.uci.edu Related Faculty/Staff Michael Cahalan, PhD Distinguished Professor and Chair, Physiology & Biophysics